Полная версия
26. Blander J. M. Regulation of the Cell Biology of Antigen Cross-Presentation. Annu. Rev. Immunol., 2018, Vol.36, pp.717–753. https://doi.org/10.1146/annurev-immunol-041015–055523.
27. Blissett A. R., Garbellini D., Calomeni E. P., Mihai C., Elton T. S., Agarwai G. Regulation of Collagen Fibrillogenesis by Cell-surface Expression of Kinase Dead DDR2. J. Mol. Biol., 2009, Vol. 385, 902–911 doi:10.1016/j.jmb.2008.10.060.
28. Blokland L. M., Hillen M. R., Kruize A. A., Meller S., Homey B., Smithson G. M. … van Roon J.. Increased CCL25 and T helper cells expressing CCR9 in the salivar glands of patients with primary sjogren’s syndrome: potential new axis in lymphoid neogenesis. Arthr. Rheumatol., 2017, Vol. 69, no.10, pp.:2038–2051. doi: 10.1002/art. 40182.
29. Braga T. T., Agudelo J. S., Camara N. O. Macrophages during the fibrotic process: M2 as friend and foe. Front Immunol., 2015, Vol. 6, Article 602. doi: 10.3389/fimmu.2015.00602.
30. Breitfeld D., Ohl L., Kremmer E., Ellwart J., Sallusto F., Lipp M. Forster R. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med., 2000, Vol. 192, no.11, pp.1545–1552. doi: 10.1084/jem.192.11.1545.
31. Bresnihan B, Pontifex E, Thurlings RM, Vinkenoog M, Gabalawy H, Fearon U…Tak P. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J. Rheumatol., 2009, Vol.36, no. 8, pp.1800–1802. doi:10.3899/jrheum.090348.
32. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D., Weinrauch Y., Zychlinsky A.. Neutrophil extracellular traps kill bacteria. Science, 2004, Vol. 303, pp. 1532–1535. doi: 10.1126/science.1092385.
33. Burrage P. S., Mix K. S., Brinckerhoff C. E. Matrix metalloproteinases: role in arthritis. Front Biosci., 2006, Vo l. 11, no. 1, pp.529–543. doi: 10.2741/1817.
34. Canna S. W., de Jesus A. A., Gouni S., Brooks S. R., Marrero B…. Golbdach-Mansky R. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat. Genet., 2014, Vol. 46, no.10, pp.1140–1146. doi: 10.1038/ng.3089.
35. Carmona-Rivera C., Zhao W., Yalavarthi, S., Kaplan, M. J. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann. Rheum., Dis. 2015, Vol.74, no.7, pp. 1417–1424. doi: 10.1136/annrheumdis-2013–204837.
36. Carulli M. T., Ong V. H., Ponticos M., Shiwen X., Abraham D. J., Black C. V., Denton C. P. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation. Arthritis Rheum., 2005, Vol. 52, no12, pp. 3772–3782. doi: 10.1002/art.21396.
37. Casciola-Rosen L. A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med., 1994, Vol. 179, no.4, pp.1317–1330. doi: 10.1084/jem.179.4.1317.
38. Chang A., Henderson S. G., Brandt D., Liu N., Guttikonda R., Hsieh C…Clark R. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J. Immunol., 2011, Vol. 186, no.3, pp.1849–1860. doi: 10.4049/jimmunol.1001983.
39. Christensen S. R., Shupe J., Nickerson K., Kashgarian M., Flavell R. A., Shlomchik M. J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006. Vol. 25, no.3, pp.417–428. doi: 10.1016/j.immuni.2006.07.013.
40. Crawford Y., Kasman I., Yu L. Zhong C., Wu X., Modrusan Z., Kaminker J., Ferrara N. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell, 2009, Vol.15, no.1, pp.21–34. doi: 10.1016/j.ccr.2008.12.004.
41. Crosby J. R., Tappan K. A., Seifert R. A., Bowen-Pope D. F. Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptor-beta expression for participation in reactive connective tissue formation in adults but not during development. Am. J. Pathol., 1999, Vol. 154, pp. 1315–1321.
42. Crotty S. Follicular helper CD4 T cells (TFH). Ann Rev Immunol., 2011, Vol. 29, pp. 621–663. doi: 10.1146/annurev-immunol-031210–101400.
43. Crow Y. J. Type I interferonopathies: a novel set of inborn errors of immunity. Ann. N. Y. Acad. Sci., 2011; 1238(1), pp.91–98. doi: 10.1111/j.1749–6632.2011.06220.x.
44. Darrah E., Rosen A. Granzyme B cleavage of autoantigens in autoimmunity. Cell Death Differ., 2010, Vol.17, no.4, pp.624–632. doi: 10.1038/cdd.2009.197.
45. De Paepe B., Creus K. K., De Bleecker J. L. Chemokines in idiopathic inflammatory myopathies. Front. Biosci., 2008, Vol. 13, pp. 2548–2577. DOI: 10.2741/2866.
46. De Paepe B., Creus K. K., De Bleecker J. L. Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr. Opin. Rheumatol., 2009, Vol. 21, no.6, pp.610–616. DOI: 10.1097/bor.0b013e3283317b31.
47. Decker P., Kotter I., Klein R., Berner B., Rammensee H. G. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology, 2006, Vol. 45, no.9, pp.1087–1095. doi: 10.1093/rheumatology/kel061.
48. Dennis G. Jr., Holweg C. T., Kummerfeld S. K., Choy D. F., Setiadi A. F., Hackney J.A…Townsend M.. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthr. Res. Ther., 2014, Vol.16, no.2, R90. doi: 10.1186/ar4555.
49. Dieguez-Gonzalez R., Calaza M., Perez-Pampin E. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis. Arthritis Rheum., 2008, Vol. 58, no.5, pp.1264–1274. doi: 10.1002/art.2342.
50. Doster R. S., Rogers L. M., Gaddy J. A., Aronoff D. M. Macrophage Extracellular Traps: A Scoping Review. J. Innate Immun., 2017, Vol.10, no.1, pp.3–13. doi: 10.1159/000480373.
51. Ek M., Popovic K., Harris H. E., Naucler C. S., Wahren-Herlenius M. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren’s syndrome. Arthritis Rheum., 2006, Vol. 54, no. 7, pp.2289–2294. doi: 10.1002/art.21969.
52. Eming S. A., Wynn T. A., Martin P. Inflammation and metabolism in tissue repair and regeneration. Science, 2017, Vol.356, pp.1026–1030. doi: 10.1126/science.aam7928.
53. Fang C., Luo T., Lin, L. The correlational research among serum CXCL13 levels, circulating plasmablasts and memory B cells in patients with systemic lupus erythematosus: a STROBE-compliant article. Medicine, 2017, 96(48), e8675. doi: 10.1097/MD.0000000000008675.
54. Feng D., Sangster-Guity N., Stone R., Korczeniewska J… Mancl M. E., Fitzgerald-Bocarsly P., Barnes B. J. Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. J. Immunol., 2010, Vol. 185, no.10, pp.6003–6012. doi: 10.4049/jimmunol.1000482.
55. Fernando M. A., Stevens C. R., Walsh E. C., Jager F., Goyette P., Plenge R., Vyse T., Rioux J.. Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis. PLoS Genet 4(4): e1000024. doi:10.1371/journal.pgen.1000024.
56. Firestein G. S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum., 1996, Vol. 39, no.11, pp. 1781–1790. doi: 10.1002/art.1780391103.
57. Garcia-Romo G. S., Caielli S., Vega B., Connolly J., Allantaz F….Pascual V. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med., 2011, Vol. 3, issue73, 73ra20. doi: 10.1126/scitranslmed.3001201.
58. Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheumatol., 1987, Vol. 30, no.11, pp.1205–1213. doi: 10.1002/art.1780301102.
59. Griffith, J. W., Sokol C. L., Luster A. D. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol., 2014, Vol. 32, pp. 659–702. doi: 10.1146/annurev-immunol-032713–120145.
60. Gross H., Hennard C., Masouris I., Cassel C., Barth S. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression. 2012; PLOS ONE 7:e42106.
61. Gupta A. K., Joshi M. B., Philippova M., Erne P., Hasler P., Hahn S., Resink T. J. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett., 2010; 584, pp.3193–3197. doi: 10.1016/j.febslet.2010.06.006.
62. Hase K., Tani K., Shimizu T, Ohmoto Y., Matsushima K., Sone S. Increased CCR4 expression in active systemic Lupus erythematosus. J. Leukocyte Biol., 2001, Vol. 70, pp. 749.
63. Helming L., Gordon S. Molecular mediators of macrophage fusion. Trends Cell Biol., 2009, Vol. 19, no.5, pp.514–522. doi: 10.1016/j.tcb.2009.07.005.
64. Hernandez-Molina G., Michel-Peregrina M., Hernandez-Ramirez D. F., Sanchez-Guerrero J., Llorente L. Chemokine saliva levels in patients with primary Sjogren’s syndrome, associated Sjogren’s syndrome, pre-clinical Sjogren’s syndrome and systemic autoimmune diseases. Rheumatology, 2011, Vol. 50, no.7, pp.1288–1292. doi: 10.1093/rheumatology/ker019.
65. Herrmann M., Voll R. E., Zoller O. M., Hagenhofer M., Ponner B. B., Kalden J. R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum.,1998, Vol.41, no.7, pp.:1241–1250. doi: 10.1002/1529- 0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H.
66. Higashi-Kuwata N., Makino T., Inoue Y., Takeya M., Ihn H. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma. Exp Dermatol., 2009, Vol. 18, no.8, pp.727–729. doi: 10.1111/j.1600–0625.2008.00828.x.
67. Higgs B. W., Liu Z., White B., Zhu W., White W., Morehouse C….Yao Y.. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann. Rheum. Dis., 2011, Vol.70, no. 11, pp. 2029–2036. doi: 10.1136/ard.2011.150326.
68. HjelmstroÈm P. Lymphoid neogenesis – de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leuk. Biol., 2001, Vol.69, pp.331–339. doi: 10.1097/BOR.0b013e32835fd8eb.
69. HjelmstroÈm P., Fjell J., Nakagawa T., Sacca R., Cuff C. A., Ruddle N. H. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol., 2000, Vol.156, no.4, pp.1133–1138. doi: 10.1016/S0002–9440(10)64981–4.
70. Horikawa S., Ishii Y., Hamashima T., Yamamoto S., Mori H., Fujimori T….Sasahara M.. PDGFRα plays a crucial role in connective tissue remodeling. Scientific RepoRts., 2015; 5:17948. doi: 10.1038/srep17948.
71. Humby F., Bombardieri M., Manzo A., Kelly S., Blades M. C., Kirkham B. Ectopic lymphoid structures support ongoing production of class- switched autoantibodies in rheumatoid synovium. PLoS Med. 2009; 6:e1. doi: 10.1371/journal.pmed.0060001.
72. Jara L. J., Medina. G., Saavedra M. A. Autoimmune manifestations of infections. Curr Opin. Rheumatol. 2018, Vol. 30, no.46, pp.373–379. DOI:10.1097/BOR.0000000000000505.
73. Jego G., Palucka A. K., Blanck J. P., Chalouni C., Pascual V., Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity, 2003, Vol. 19, no.2, pp.225–234. doi: 10.1016/s1074–7613(03)00208–5.
74. Jenkins M. K., Khoruts A., Ingulli E., Mueller D. L., McSorley S. J., Reinhardt R., Itano A., Pape A. In vivo activation of antigen- specific CD4 T cells. Annu. Rev. Immunol., 2001, Vol.19, pp. 23–45. doi: 10.1146/annurev.immunol.19.1.23.
75. Jesus A. A., Goldbach-Mansky R. IL-1 blockade in autoinflammatory syndromes. Annu. Rev. Med., 2014, Vol. 65, pp.223–244. doi: 10.1146/annurev-med-061512–150641.
76. Jorch S., Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. NATURE MEDICINE, 2017, Vol. 23, no.3, pp. 279–287. doi:10.1038/nm.4294.
77. Jurewicz М. М., Stern. L. G. Class II MHC antigen processing in immune tolerance and inflammation. Immunogenetics, 2019, Vol. 71, no.3, pp.171–187. doi:10.1007/s00251–018–1095-x.
78. Kang Y. M., Zhang X., Wagner U. G. Yang H., Beckenbaugh R. D., Kurtin P.J…Weyand C. M. CD8 T Cells Are Required for the Formation of Ectopic Germinal Centers in Rheumatoid Synovitis. J. Exp. Med., 2002, Vol. 195, no.10, pp. 1325–1336. doi.org/10.1084%2Fjem.20011565.
79. Khandpur R., Carmona-Rivera C., Vivekanandan-Giri A., Gizinski A., Yalavarthi S., Knight J. S. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl. Med., 2013; 5(178):178ra40. doi: 10.1126/scitranslmed.3005580.
80. Kiselyov A. et al. VEGF/VEGFR signaling as a target for inhibiting angiogenesis. Expert Opin. Investig. Drugs, 2007, Vol. 16, pp. 83–107.
81. Klemperer P. The concept of collagen diseases. The American Journal of Pathology, 1950; Vol. XXVI, no. 4, pp. 505–519.
82. Knecht, H., Saremaslani, P., Hedinger, C. Immunohistological findings in Hashimoto’s thyroiditis, focal lymphocytic thyroiditis and thyroiditis de Quervain. Virchows Arch., 1981; A 393, pp. 215–231. https://sci-hub.do/10.1007/bf00431078.
83. Knight J. S., Carmona-Rivera C., Kaplan M. J. Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases. Front Immunol., 2012, Vol. 3, pp.380. doi: 10.3389/fimmu.2012.00380. eCollection 2012.
84. Kobayashi K., Kaneda K., Kasama T. Immunopathogenesis of Delayed-Type Hypersensitivity. Microscopy Research and Technique, 2001, Vol. 53, no.4, pp. 241–245. doi: 10.1002/jemt.1090.
85. Koch A. E. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum., 1998, Vol. 41, no.6, pp.951–962. doi:10.1002/1529–0131(199806)41:6<951::AID-ART2>3.0.CO;2-D.
86. Koelink P. J., Overbeek. S. A., Braber S., Henricks P. A., Roda M.A….Kraneveld A. D.. Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease. Gut. 2014, Vol. 63, no.4, pp.578–587. doi:10.1136/gutjnl-2012–303252.
87. Kraan M. C., Haringman J. J., Post W. J., Versendaal J., Breedveld F. C., Tak P. P. Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology, 1999, Vol. 38, no.11, pp.1074–1080. doi: 10.1093/rheumatology/38.11.1074.
88. Krenn V., Souto-Carneiro M. M., Kim H. J., Berek C., Starostik P., Konig A. Histopathology and molecular pathology of synovial B-lymphocytes in rheumatoid arthritis. Histol. Histopathol., 2000, Vol. 15, pp. 791–798. doi: 10.14670/HH-15.791.
89. Kroenke M. A., Eto D., Locci M., Cho M., Davidson T., Haddad E. K., Crotty S. Bcl6 and Maf cooperate to instruct human follicular helper CD4T cell differentiation. J Immunol., 2012, Vol. 188, no.8, pp.3734–3744. doi: 10.4049/jimmunol. 1103246.
90. Kuivaniemi H., Tromp G. Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases. Gene, 2019. Vol 707, pp. 151–171 https://doi.org/10.1016/j.gene.2019.05.003.
91. Kunnumakkara A. B., Sailo B. L., Banik K., Harsha C., Prasad S…Aggarwal B. B. Chronic diseases, inflammation, and spices: how are they linked? J. Transl. Med., 2018; 16:14. doi: 10.1186/s12967–018–1381–2.
92. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y. H., Homey B…. Gillet M. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature, 2007, Vol. 449, pp. 564–569. doi: 10.1038/nature06116.
93. Lau C. M., Broughton C., Tabor A. S., Akira S., Flavell R. A., Mamula M…Marshak-Rothstein A. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med., 2005, Vol. 202, no.9, pp.1171–1177. doi: 10.1084/jem.20050630.
94. Leadbetter E. A., Rifkin I. R., Hohlbaum A. M., Beaudette B. C., Shlomchik M. J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature, 2002, Vol. 416, pp.603–607.
95. Liao A. P., Salajegheh M., Nazareno R., Kagan J. C., Jubin R. G. Greenberg S. A.. Interferon β is associated with type 1 interferon-inducible gene expression in dermatomyositis. Ann Rheum Dis., 2011, Vol. 70, no.5, pp.831–836. doi: 10.1136/ard.2010.139949.
96. Loo J., Spittle D. A., Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax Published Online First: 06 January 2021. doi: 10.1136/thoraxjnl-2020–216243.
97. Ma W-T., Gao F., Gu K., Chen D-K. The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review. Front. Immunol., 2019; 10:1140. doi: 10.3389/fimmu.2019.01140.
98. Malmstrom V., Venalis P., Albrecht I. T cells in myositis. Arthritis Res. Ther., 2012; 14(6), 230. doi.org/10.1186/ar4116.
99. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol., 2002, Vol. 23, no.11, pp.549–555. doi: 10.1016/s1471–4906(02)02302–5.
100. Manzo A., Bombardieri M., Humby F., Pitzalis C. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. Immunol Rev., 2010, Vol. 233, pp.267–285. doi: 10.1111/j.0105–2896.2009.00861.x.
101. Masters S. L., Simon A., Aksentijevich I., Kastner D. L. Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease. Annu. Rev. Immunol., 2009, Vol. 27, pp.621–668. doi: 10.1146/annurev.immunol.25.022106.141627.
102. McNally A. K., Anderson J. M. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am. J. of Pathology, 1995, Vol. 147, no.5, pp. 1487–1499.
103. McNally A. K., Jones J. A., Macewan S. R., Colton E., Anderson J. M. Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. Journal of Biomedical Materials Research, 2008, Vol. 86, no. 2, pp. 535–543. doi: 10.1002/jbm.a.31658.
104. Means T. K., Latz E., Hayashi F., Murali M. R., Golenbock D. T., Luster A. D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Investig., 2005, Vol. 115, no. 2, pp. 407–417. doi: 10.1172/JCI23025.
105. Miga A., Masters S., Gonzalez M., Noelle R. J. The role of CD40-CD154 interactions in the regulation of cell mediated immunity. Immunological Investigations, 2000, Vol.29, no 2, pp. 111–114. doi: 10.3109/08820130009062292.
106. Miyabe Y., Lian, J., Miyabe, C., Luster, A. D. Chemokines in rheumatic diseases: pathogenic role and therapeutic implications. Nature Reviews Rheumatology, 2019, 15:731–46. doi:10.1038/s41584–019–0323–6.
107. Moghaddas F., Masters S. L. Monogenic autoinflammatory diseases: cytokinopathies. Cytokine, 2015, Vol. 74, no.2, pp.237–246. doi: 10.1016/j.cyto.2015.02.012.
108. Moore B. B., Keane M. P., Addison C. L., Arenberg D. A., Strieter R. M., CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J. Invest. Med., 1998, Vol. 46, p. 113.
109. Murphy G., Knauper V., Atkinson S., Butler G., English W, Hutton M., Stracke J., Clark I. Matrix metalloproteinases in arthritic disease. Arthritis Res., 2002, 4(Suppl 3):S39–S49. doi: 10.1186/ar572.
110. Murshid A., Gong J., Calderwood S. K. The role of heat shock proteins in antigen cross presentation. Front. Immunol., 2012, Vol.3, Article63. doi: 10.3389/fimmu.2012.00063. eCollection.
111. Nakhasi H. L., Ramanujam M., Atreya C. D., Hobman T. C., Lee N. Rubella virus glycoprotein interaction with the endoplasmic reticulum calreticulin and calnexin. Arch. Virol., 2001, Vol. 146, pp.1–14.
112. Nanki T., Hayashida K., El-Gabalawy H., Suson S., Shi K., Girschick H. J., Yavus S., Lipsky P. E. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T-cell accumulation in rheumatoid arthritis synovium. J Immunol., 2000, Vol. 165, no. 11, pp. 6590–6598. doi: 10.4049/jimmunol.165.11.6590.
113. Nanki T., Shimaoka T., Hayashida K., Taniguchi K., Yonehara S., Miyasaka N.. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum., 2005, Vol. 52, no.10, pp. 3004–3014. doi: 10.1002/art.21301.
114. Ohtani H. Granuloma cells in chronic inflammation express CD205 (DEC205) antigen and harbor proliferating T lymphocytes: Similarity to antigen-presenting cells. Pathology International, 2013, Vol. 63, pp. 85–93. doi:10.1111/pin.12036.
115. Orr C., Najm A., Biniecka M., McGarry T., Ng C. T., Young F., Fearon U., Veale D. J.. Synovial immunophenotype and anti-citrullinated peptide antibodies in rheumatoid arthritis patients: relationship to treatment response and radiologic prognosis. Arthr. Rheumatol., 2017, Vol. 69, no. 11, pp.2114–2123. doi: 10.1002/art. 40218.
116. Pagan A. J., Ramakrishnan L. The Formation and Function of Granulomas. Annu. Rev. Immunol., 2018, 36:23.1–23.27. https://doi.org/10.1146/annurev- immunol- 032712- 100022.
117. Page C., Francois C., Goeb V., Duverlie G. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses. J. Clin. Virol., 2015, Vol. 72, pp.69–74.
118. Pap T., Shigeyama Y., Kuchen S., Fernihough J. K., Simmen B., Gay R. E. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum., 2000, Vol. 43, no. 6, pp.1226–1232. doi: 10.1002/1529–0131(200006)43:6<1226::AID-ANR5>3.0.CO;2–4.
119. Patel D. D., Zachariah J. P., Whichard L. P. CXCR3 and CCR5 ligands in the rheumatoid arthritis synovium. Clin. Immunol., 2001, Vol. 98, no.1, pp. 39–45. doi: 10.1006/clim.2000.4957.
120. Pisetsky D. S., Erlandsson-Harris H., Andersson U. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Research & Therapy, 2008, 10:209. doi:10.1186/ar2440.
121. Pitzalis C., Kelly S., Humby F. New learnings on the pathophysiology of RA from synovial biopsies. Curr Opin Rheumatol., 2013, Vol. 25, no.3, pp. 334–344. doi: 10.1097/BOR.0b013e32835fd8eb.
122. Randen, I., Mellbye, O. J., Forre, O., Natvig, J. B. The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue. Scand. J. Immunol., 1995, Vol.41, no. 5, pp. 481–486. doi: 10.1111/j.1365–3083.1995.tb03596.x.
123. Raychaudhuri S., Sandor C., Stahl E. A., Freudenberg J., Lee H.S….de Bakker P. I. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet., 2012, Vol. 44, no.3, pp.291–296. doi: 10.1038/ng.1076.
124. Reglero-Real N., Colom B., Bodkin J. V., Nourshargh S. et al. Endothelial Cell Junctional Adhesion Molecules: Role and Regulation of Expression in Inflammation. Arterioscler Thromb Vasc Biol., 2016, Vol. 36, no.10, pp. 2048–2057. doi: 10.1161/ATVBAHA.116.307610.